Recent Articles from Investor Brand Network

HeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how cardiac conditions are identified and monitored, positioning its solutions at the intersection of rising clinical need and evolving innovation. “One of the most persistent challenges in cardiac care is pre-hospital delay, with many patients not seeking medical attention at the onset of symptoms. Traditional electrocardiogram testing is typically conducted in clinical environments, which may not coincide with the onset of symptoms such as intermittent chest pain, palpitations or other warning signs. As a result, patients often defer care and clinicians are left without the data needed to make timely, informed decisions,” reads a recent article.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, has announced that it has signed a Letter of Intent (LOI) for $100 million of proposed funding under the U.S. CHIPS and Science Act, which is administered by the U.S. Department of Commerce. In connection with executing final award documents, D-Wave would issue $100 million in shares of its common stock to the U.S. Department of Commerce. The LOI marks a significant endorsement by the U.S. government of D-Wave’s annealing and gate-model quantum computing technologies and their potential impact on the U.S. economy.

Xeriant (OTCQB: XERI) announced it has entered into a memorandum of understanding with UAV Corp. (OTCPK: UMAV) to explore a potential merger or acquisition, alongside opportunities to integrate Xeriant’s advanced materials technologies into UAV’s lighter-than-air airships and drone platforms. The companies said the proposed combination would unite capabilities in advanced materials, quantum AI, hybrid propulsion and unmanned aerial systems, with the long-term goal of pursuing an uplisting to Nasdaq or the NYSE.

Jeff Bezos, the founder of Amazon, has cast doubt on the accuracy of many of the timelines that have been provided by rival companies with ambitions of establishing data centers in outer space.

The market for tokenized real-world assets (RWAs) is approaching the $30 billion mark on blockchain networks, yet only a small share is actively participating in decentralized finance.

Microgrids are increasingly becoming attractive as a way to achieve cost efficiency and resilience while providing reliable energy for data centers amid exploding growth in the AI industry.

There are few opportunities in the global oil and gas sector as compelling as the Jameson Land Basin in Greenland, widely viewed as one of the world’s largest remaining underexplored onshore basins. Spanning more than 8,400 square kilometers (roughly 2 million acres), the basin has been the subject of extensive geological and seismic analysis over several decades, with historical industry estimates suggesting the broader basin system could contain tens of billions of barrels of oil equivalent.

For decades, coal’s critics and coal’s defenders have been arguing about the same thing: whether to burn it. Frontieras North America Inc. has a different question entirely. What happens when the industry stops burning coal and starts fractionating it?

Platinum prices have recently lost some momentum and remain below the $2,000-per-ounce level despite an earlier rally. However, market fundamentals suggest the metal could still be positioned for stronger gains ahead as tightening supply and declining inventories continue to support its outlook.

Electric vehicle sales in China as well as Europe have crossed a critical threshold that researchers say has initiated an irrevocable transition away from internal combustion engine vehicles to EVs. Analysis of global sales data from 2016 through 2023 shows electric vehicle adoption ramping up exponentially in 32 nations, with the worldwide fleet doubling every 18 months.

Researchers at the University of Virginia have conducted a study that offers new insights into what happens when there are errors in the process of brain cells dividing to form new cells as the brain is growing. Their findings could open the door to treating cancer and many developmental disorders of the brain.

If you have been following precious metal prices for a few months, you may be wondering why the price of silver often pulls back much harder than the price of gold during those retreats. We explain why this usually happens.

The global shift to renewable energy is creating unexpected demand for circuit breakers, those behind-the-scenes components that rarely make headlines. SkyQuest valued the market at $6.68 billion in 2024, projecting it will reach $10.36 billion by 2033 on roughly 5% annual growth. Behind much of that growth is the rapid buildout of solar and wind capacity, which requires considerably more electrical protection infrastructure than most people realize.

Iran has introduced a new maritime insurance system that allows shipping firms to pay premiums using crypto, marking another step in the country’s broader push to reduce dependence on traditional financial networks while operating under international sanctions.

Standard Chartered Bank is preparing for major changes as it works to improve profits and strengthen its future business operations. The London-based bank, commonly known as StanChart, recently announced plans to cut more than 7,000 jobs by 2030 while increasing its investment in technology, automation, and artificial intelligence.

Knee cartilage damage remains one of the most stubborn problems in orthopedic medicine. Unlike many other tissues in the body, articular cartilage has little natural ability to heal because it lacks both direct blood supply and the biological machinery required for meaningful regeneration. For decades, treatment options have reflected that limitation. Microfracture, the long-standing standard of care, attempts to stimulate repair by drilling into the underlying bone in an attempt to mimic a repair trigger. It can provide short-term symptom relief, but long-term cartilage durability remains a recognized challenge with standard treatment. More advanced cell-based therapies exist, but they introduce substantial complexity, cost, manufacturing requirements, and long procedural delays that limit broader adoption. Despite roughly 472,500 arthroscopic knee procedures in the U.S. each year involving knee cartilage damage, the market still lacks an approved, ready-to-use truly regenerative solution capable of combining procedural simplicity with sustained long-term outcomes. Regentis is positioning durability as a central differentiator, with clinical data demonstrating sustained outcomes over extended follow-up periods.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

This article has been disseminated on behalf of InPlay Oil Corp. and may include paid advertising.

Commercial drivers and other safety-sensitive transportation workers will remain subject to penalties if they use state-legal medical marijuana, according to updated guidance from the Department of Transportation (DOT).

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.

GlobalTech (OTC: GLTK) reported first-quarter 2026 net revenue of approximately $10.4 million, up from approximately $4.3 million in the prior-year period, primarily driven by contributions from its 51% ownership interest in 123 Investments Limited, operator of the Moda in Pelle premium footwear platform, acquired in December 2025. The company reported total assets of approximately $100.8 million and shareholders’ equity of approximately $36.1 million as it continues integrating its expanded operating portfolio.

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include paid advertising.

Artificial intelligence is no longer a buzzword in the life sciences; rather, it is rapidly becoming the defining infrastructure layer of modern drug development. The companies that control the most intelligent platforms may ultimately control the industry’s future. Among the clinical-stage players quietly positioning themselves at the center of this shift is Oncotelic Therapeutics (OTCQB: OTLC ), a California-based oncology company that has spent years building a proprietary AI platform and is now turning that platform into something more ambitious than a drug-discovery tool.

Resilient Energy (OTCID: RENI) announced that its wholly owned subsidiary, Bullet SWD LLC, has entered into a joint venture agreement with an established U.S.-based oilfield services operator generating more than $15 million in annual revenue, with a customer base that includes multiple Fortune 500 energy companies. Under the agreement, RENI will supply and maintain specialized equipment supporting saltwater disposal and related oilfield operations, with the company expecting the partnership to create a high-margin revenue stream and begin generating initial revenue before the end of summer 2026.

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising.

Resilient Energy (OTCID: RENI) announced that its wholly owned subsidiary, Bullet SWD LLC, has entered into a joint venture agreement with an established U.S.-based oilfield services operator generating more than $15 million in annual revenue, with a customer base that includes multiple Fortune 500 energy companies. Under the agreement, RENI will supply and maintain specialized equipment supporting saltwater disposal and related oilfield operations, with the company expecting the partnership to create a high-margin revenue stream and begin generating initial revenue before the end of summer 2026.

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.

Gold prices moved slightly higher at the start of the week as the U.S. dollar weakened, making the precious metal more attractive to overseas buyers. However, gains remained limited due to rising Treasury yields and surging oil prices, both of which intensified concerns over inflation and the possibility of tighter monetary policy.

Bipartisan House legislation that would impose a $130 annual charge on electric vehicles and $35 on certain plug-in hybrids has been introduced. Brought forth by Representatives Rick Larsen and Sam Graves, the measure is part of a five-year highway reauthorization totaling $580 billion before current law expires on September 30 and is designed to fund transport infrastructure repairs.

Unlike prostate, colon and breast cancers, the screening for lung cancer hasn’t been very successful. This is largely because screening focuses on just one risk factor, smoking history, yet many people who develop the disease don’t have a history of smoking. Now, scientists have made progress in developing a blood test that could help in flagging individuals who are at a higher risk of developing lung cancer.

Lawmakers have introduced new legislation aimed at creating a more consistent approach to how federal agencies handle AI.

Beijing’s historic pivot toward electricity-fueled economic operations is delivering strategic benefits that extend beyond simple petroleum independence, advantages that are now being magnified by recent Middle Eastern hostilities. Commentary typically focuses on reduced vulnerability to supply chain disruptions, but tends to miss a key factor.

Samsung is working on a new type of battery that could change the future of electric vehicles. This new design is called a solid-state battery, and it uses a combination of silver and carbon to improve how the battery works. While current lithium-ion batteries have helped electric cars become more popular, they still face challenges such as limited range, slow charging, and safety risks. Samsung’s new approach aims to solve these problems.

Xeriant (OTCQB: XERI) highlighted Colorado’s implementation of new statewide wildfire resiliency building codes, which the company said reflect a growing national shift toward fire-resistant and non-combustible construction standards. Xeriant said the evolving regulatory environment could increase demand for advanced building technologies such as its NEXBOARD(TM) composite panel platform and NexPatch(TM) fire-resistant joint compound as it continues testing, certification and commercialization efforts for its construction materials portfolio.

BioAdaptives (OTC: BDPT) a science-driven health and wellness company, announced the launch of MyndSystem, a dual-phase cognitive support platform combining its daytime MyndMed formula with newly released nighttime recovery product MyndRenew into a 24-hour stimulant-free cognitive support system. The company said MyndSystem was originally developed for professional combat athletes and is designed to address both daytime mental performance and overnight neural recovery.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

GlobalTech (OTC: GLTK) reported first-quarter 2026 net revenue of approximately $10.4 million, up from approximately $4.3 million in the prior-year period, primarily driven by contributions from its 51% ownership interest in 123 Investments Limited, operator of the Moda in Pelle premium footwear platform, acquired in December 2025. The company reported total assets of approximately $100.8 million and shareholders’ equity of approximately $36.1 million as it continues integrating its expanded operating portfolio.

ParaZero Technologies (NASDAQ: PRZO) announced the successful completion of its first live U.S. demonstration of its DefendAir counter-UAS net launcher system following SOF Week 2026 in Tampa, showcasing the platform to defense and security stakeholders including Tier-1 defense integrators, special forces, law enforcement representatives and distributors. During the demonstration, the DefendAir system achieved a 100% success rate intercepting multiple fast incoming FPV drone threats, supporting discussions around potential procurement, integration and deployment opportunities in U.S. and international defense markets.

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

American Fusion (OTC: AMFN), a company developing advanced fusion energy technologies, including its Texatron(TM) Fusion Engine(TM) platform, filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, marking its first quarterly report reflecting the consolidated operations of American Fusion and Kepler Fusion Technologies following the closing of the previously announced reverse-merger share exchange on Feb. 27, 2026.

Sunshine Biopharma (NASDAQ: SBFM) announced the closing of its previously announced public offering, generating approximately $6 million in gross proceeds before fees and expenses through the sale of 12 million common units, each including common stock or pre-funded warrants and two Series C warrants. The company said net proceeds will be used for general corporate purposes and working capital, with potential additional gross proceeds of approximately $12 million if the Series C warrants are fully exercised for cash, while Aegis Capital acted as exclusive placement agent.

SoundHound AI (NASDAQ: SOUN) reported first-quarter 2026 revenue of $44.2 million, up 52% year over year, while reaffirming full-year revenue guidance of $225 million to $260 million and ending the quarter with $216 million in cash and no debt. The company said core automotive and IoT AI revenue grew 88% excluding acquisitions, reflecting continued demand across its voice and agentic AI business.

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently announced financial and operating results for fiscal Q2 2026, which ended March 31, 2026 ( https://nnw.fm/QfJFi ). According to the Chairman of Forward Industries, Kyle Samani, the second fiscal quarter for Forward was “defined by disciplined execution across the business — sharpening our cost structure, strengthening our balance sheet, and deepening our engagement within the Solana ecosystem.”

This article has been disseminated on behalf of Quarterhill Inc . and may include paid advertising.

Ring Energy (NYSE American: REI) announced the pricing of its underwritten public offering of 44,444,445 shares of common stock at $1.35 per share, generating expected gross proceeds of approximately $60 million, excluding any exercise of the underwriters’ option to purchase additional shares. The company said net proceeds will primarily be used to repay outstanding borrowings under its senior secured revolving credit facility, with any remaining funds allocated to general corporate purposes, while Mizuho, BofA Securities and Raymond James are serving as joint book-running managers for the offering.

Ideal Power (NASDAQ: IPWR) announced a definitive agreement with institutional investors for a $30 million registered direct offering priced at the market under Nasdaq rules, with proceeds expected to support commercialization of its B-TRAN(R) bidirectional semiconductor power switch, including customer design-ins, custom development programs and initial production ramp efforts with strategic partners. Titan Partners, a division of American Capital Partners, is acting as sole placement agent for the financing, which the company said strengthens its balance sheet as it pursues growing opportunities tied to power efficiency demand across data center and industrial markets.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Cardio Diagnostics Holdings (NASDAQ: CDIO), took the spotlight in the latest episode of The BioMedWire Podcast, featuring CEO and Co-Founder Dr. Meesha Dogan discussing the company’s mission to improve cardiovascular disease prevention and early detection through precision medicine powered by epigenetics, genetics and artificial intelligence. During the interview, Dogan also highlighted Cardio Diagnostics’ expansion into India through partnerships with Aimil Ltd. and Dr. Lal PathLabs, as well as the company’s progress through the Medicare reimbursement process, noting that CPT coding and payment steps have been completed while coverage determination remains underway.

Datavault AI (NASDAQ: DVLT) announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to create DelivMeds AI, a healthcare platform combining AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification and direct-to-consumer healthcare delivery through three concurrent transactions, including an expanded PharmacyChain(TM) license, acquisition of QOLPOM intellectual property and a controlling stake in Tollo Health. The combined transactions carry an expected approximate asset value of $4 billion, subject to an independent fairness opinion, and are intended to support a national rollout of data-driven healthcare delivery and patient engagement solutions.

For decades, modern cybersecurity has depended on encryption systems designed to keep sensitive information safe from hackers and cybercriminals. From online banking and email communication to medical records and cryptocurrency wallets, encryption acts as the invisible shield protecting digital life. However, experts are now warning that the rapid development of quantum computing could soon threaten the security foundations of the internet itself.

University of North Carolina scientists have engineered immune cells that can destroy acute myeloid leukemia while sparing healthy blood tissue, overcoming a limitation that has plagued standard treatments, which have struggled to separate cancerous cells from normal cells. Immunologist Gianpietro Dotti and hematologist Paul Armistead directed research teams whose work appears in the journal Blood , offering an approach that may expand options for patients battling this deadly disease.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Telomir Pharmaceuticals (NASDAQ: TELO) announced publication of peer-reviewed preclinical data in Advances in Redox Research showing that Telomir-Zn delivered dose-dependent survival improvements and multiple therapeutic benefits in a Wilson’s disease model, including reduced oxidative stress, lower hepatic copper burden and improved liver function markers. The findings support the biological activity of Telomir-Zn in Wilson’s disease and expand the company’s scientific validation as it advances its lead triple-negative breast cancer program toward Phase 1/2 clinical initiation.

Cardio Diagnostics Holdings (NASDAQ: CDIO), took the spotlight in the latest episode of The BioMedWire Podcast, featuring CEO and Co-Founder Dr. Meesha Dogan discussing the company’s mission to improve cardiovascular disease prevention and early detection through precision medicine powered by epigenetics, genetics and artificial intelligence. During the interview, Dogan also highlighted Cardio Diagnostics’ expansion into India through partnerships with Aimil Ltd. and Dr. Lal PathLabs, as well as the company’s progress through the Medicare reimbursement process, noting that CPT coding and payment steps have been completed while coverage determination remains underway.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Annovis Bio (NYSE: ANVS) announced the pricing of an underwritten public offering of 7,895,000 shares of common stock and accompanying warrants to purchase up to 7,105,500 additional shares at a combined offering price of $1.90 per share and warrant. The company expects gross proceeds of approximately $15 million before expenses, with net proceeds intended to support continued clinical development of buntanetap for Alzheimer’s and Parkinson’s disease, as well as working capital and general corporate purposes.

Safe Pro Group (NASDAQ: SPAI) announced progress in its AI-powered threat detection collaboration with Lantronix (Nasdaq: LTRX), marking a milestone in integrating Safe Pro’s SPOTD AI technology with Lantronix’s System-on-Module platform for real-time robotic edge processing. Following a 120-day development cycle, the collaboration positions the solution for broader deployment across next-generation autonomous air, ground and sea platforms, expanding Safe Pro’s reach in defense and commercial markets through edge-native AI processing that eliminates cloud dependence.

Scinai Immunotherapeutics (NASDAQ: SCNI) announced the appointment of Eilon Elmalem as site head of its wholly owned subsidiary Scinai Biopharma Services’ Yavne CDMO facility, effective June 14, 2026. Elmalem, who has supported the company as an external consultant for the past two years, brings more than two decades of biotechnology and pharmaceutical operations experience and will oversee site operations and engineering activities as Scinai continues expanding its contract development and manufacturing platform.

Rail Vision (NASDAQ: RVSN, FSE: C80) announced that its majority-owned subsidiary, Quantum Transportation Ltd., has successfully delivered a working integration layer that incorporates a publicly accessible experimental surface-code dataset from Google Quantum AI into its patent-pending quantum error correction transformer pipeline. The milestone advances Quantum Transportation’s transformer-based quantum decoder technology beyond internal data environments, reducing technical risk while establishing a scalable foundation for training and benchmarking neural quantum error correction systems using external experimental datasets.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) FSE: (Y2F) and may include paid advertising.

Annovis Bio (NYSE: ANVS), a Phase 3 clinical-stage biotechnology company developing buntanetap for neurodegenerative diseases, announced a proposed underwritten public offering of common stock and accompanying warrants. The company intends to use net proceeds to support continued clinical development of buntanetap in a Phase 3 Alzheimer’s disease study, as well as for working capital and general corporate purposes.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) is moving beyond its roots as a clinical-stage biotechnology company into the quickly expanding intersection of artificial intelligence and industrial automation. “Through two closely aligned announcements, the firm has unveiled a strategic partnership with TechForce Robotics, which positions it to commercialize a next-generation, AI-enhanced platform created for regulated pharmaceutical environments,” reads a recent article. “At the core of this pivot is Oncotelic’s proprietary PDAOAI platform, an AI-driven system designed to improve compliance, monitoring, and operational intelligence. By integrating this innovation with TechForce Robotics’ hardware and manufacturing expertise, the companies aim to deliver a GMP-compliant robotics solution capable of automating critical workflows in pharmaceutical production and laboratory settings.”

Perpetuals.com (NASDAQ: PDC) announced the launch of UpsideOnly, a risk-free trading and market prediction platform that combines a proprietary AI algorithm with crowd intelligence to generate trading signals across global financial markets. Powered by the company’s patent-pending BayesShield AI trained on more than 22 billion executed retail trades, the platform enables users to make market predictions without risking personal capital, while Perpetuals executes trades using its own funds and shares profits from successful trades with participating users.

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.